FDA Gives Green Light to New Covid-19 Vaccines Targeting XFG Variant
By Editor • August 28, 2026 • 1 min read
The US Food and Drug Administration (FDA) has officially approved updated Covid-19 vaccines aimed at the prevalent XFG variant, paving the way for manufacturers to distribute doses nationwide.
On Thursday, the FDA confirmed its endorsement of new formulations from Moderna, Novavax-Sanofi, and Pfizer-BioNTech, following recommendations from an advisory panel that emphasized the need for these vaccines to address the current dominant strain.
As shipments of the vaccines begin, questions persist regarding insurance coverage, leaving many to wonder about the financial implications of receiving the updated shots.
Source: www.theguardian.com
#COVID-19 #FDA #Moderna #Pfizer-BioNTech #vaccines #XFG variant
